Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
34.97 (1y: +46%)
Market Cap 1.39 B P/E(ttm) 9.80
Enterprise Value 1.11 B P/B 3.70
ACOR- NAS (USA)
Acorda Therapeutics, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$34.97
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,388Revenue $M306Net Margin (%)50.7Z-Score5.4
Enterprise Value $M1,109EPS $3.6Operating Margin %8.4F-Score5
P/E(ttm))9.8Cash Flow Per Share $1.5Pre-tax Margin (%)7.9Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %0Quick Ratio3.8Cash flow > EarningsN
Price/Sales4.65-y EBITDA Growth Rate %0Current Ratio3.6Lower Leverage y-yY
Price/Cash Flow16.4y-y EBITDA Growth Rate %-59.7ROA % (ttm)27.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)40.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.3ROI % (ttm)15.4Gross Margin Increase y-yY

Gurus Latest Trades with ACOR

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
ACORJoel Greenblatt 2012-12-31 Sold Out -0.02%$22.48 - $26.93
($24.61)		 $ 34.9742%Sold Out0
ACORJoel Greenblatt 2012-06-30 Buy 0.02%$21.61 - $27.02
($23.73)		 $ 34.9747%New holding, 9329 sh.9,329
ACORJohn Burbank 2012-03-31 Sold Out -0.21%$24.85 - $27.49
($24.24)		 $ 34.9744%Sold Out0
ACORMario Gabelli 2011-03-31 Sold Out $20.6 - $30.98
($23.63)		 $ 34.9748%Sold Out0
ACORMario Gabelli 2010-12-31 Buy $25.05 - $31.32
($27.26)		 $ 34.9728%New holding, 10000 sh.10,000
ACORCarl Icahn 2007-12-31 Sold Out -0.01%$17.21 - $22.11
($19.6)		 $ 34.9778%Sold Out0
ACORCarl Icahn 2007-09-30 Buy 0.01%$16.63 - $20.7
($18.3)		 $ 34.9791%New holding, 16293 sh.16,293
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 7

ACOR is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Premium Most recent portfolio changes are included for Premium Members only!


ACOR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COHEN RONPresident and CEO 2013-06-10Sell11,000$34.15-2.64view
PANEM SANDRA PHDDirector 2013-05-08Sell10,000$33.8-1.63view
Sabella Lauren MExec. VP-Commercial Dvlpmnt 2012-12-04Sell4,364$24.5835.27view
Blight AndrewChief Scientifc Officer 2012-12-03Sell7,200$24.237.4view
Carrazana Enrique J.Chief Medical Officer 2012-12-03Sell800$24.535.71view
COHEN RONPresident and CEO 2012-12-03Sell16,407$24.2237.28view
Wasman JanePresident, Intl and GC 2012-12-03Sell7,019$24.237.4view
LAWRENCE DAVIDCFO 2012-12-03Sell9,313$24.2137.34view
Randall LorinDirector 2012-11-28Sell10,198$24.734.62view
PANEM SANDRA PHDDirector 2012-11-13Sell22,569$24.1237.85view

Press Releases about ACOR :

Quarterly/Annual Reports about ACOR:

News about ACOR:

Articles On GuruFocus.com
Fv 58 MSN 10 Apr 19 2013 
5 Speculative Biotech Stocks to Consider Buying Now Jan 24 2012 
Acorda Therapeutics Inc. Reports Operating Results (10-K) Mar 01 2011 
Steve Cohen Buys ACOR, DPZ, GXDX, NDN, and OREX Feb 07 2011 
Acorda Therapeutics Inc. (ACOR) President and CEO Ron Cohen sells 15,000 Shares Dec 03 2010 
Acorda Therapeutics Inc. (ACOR) CFO David Lawrence sells 10,905 Shares Dec 03 2010 
Acorda Therapeutics Inc. Reports Operating Results (10-Q) Aug 09 2010 
Acorda Therapeutics Inc. (ACOR) President and CEO Ron Cohen sells 55,000 Shares Aug 09 2010 
Acorda Therapeutics Inc. Reports Operating Results (10-Q) May 10 2010 
Acorda Therapeutics Inc. (ACOR) CFO David Lawrence sells 12,000 Shares Mar 12 2010 

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK